Abstract Ethyl 4-amino-2-fluorophenylpiperazin-1-carboxylates containing a 1,3-oxazol(idin)e, 5-thioxo-1,2,4-triazole, 1,3,4-thiadiazole, 5-thioxo-1,3,4-oxadiazole, or 1,3-thiazole nucleus were obtained starting from ethyl piperazine-1-carboxylate (1) by several steps. The treatment of amine, 3 or hydrazide, 9 with several aromatic aldehydes generated the corresponding arylmethyleneamino (3a-f) or arylidenehydrazino (12a-c) compounds. The Mannich reaction between the 1,2,4-triazole or 1,3,4-oxadiazole compounds and 7-aca produced cephalosporanic acid derivatives. Penicillanic acid derivatives were obtained when 6-apa was used in the Mannich reactions. The synthesized compounds were screened for their antimicrobial, antilipase, and antiurease activities. Some of them were found to possess good-moderate antimicrobial activity against the test microorganisms. Two compounds exhibited antiurease activity, and four of them displayed antilipase activity.
Introduction
The limitations of the existing antibacterial drugs caused by various reasons including drug resistance, the serious side effects, and/or lack of efficacy made infectious diseases a vicious cycle. In addition, the treatment of resistant strains requires a prolonged therapy containing the use of more toxic drugs and increases the financial burden. The rising prevalence of multi-drug resistant bacteria continues to serve medicinal chemists to search and discove novel antimicrobial agents effective against pathogenic microorganisms resistant to current treatment.
Among the strategies addressed to the synthesis of compounds possessing antimicrobial activity, the syntheses of hybrid molecules incorporating different heterocyclic moieties have been attracting widespread attention (Mallikarjuna et al., 2009) .
A number of N-containing heterocyclic compounds constitute important building blocks in organic and medicinal chemistry. For example, triazoles have been shown to possess a number of desirable activities in the context of medicinal chemistry. Ribavirin (antiviral), rizatriptan (antimigraine), alprazolam (psychotropic), fluconazole, and itraconazole (antifungal) are the best examples for potent drugs possessing triazole nucleus Walczak et al., 2004; Jones et al., 1965; Ashok et al., 2007) . Tazobactam, a b-lactamase inhibitor is the other best known example of triazole containing structures with the broad spectrum antibiotic piperacillin (Kategaonkar et al., 2010) .
Substituted piperazines constitute another class of important pharmacophores, which are found in many marketed drugs, such as the HIV protease inhibitor, Crixivan (Chaudhary et al., 2006) . Ciprofloxacin, norfloxacin, pefloxacine, ofloxacin, and enoxacin are fluoroquinolone class antibacterial drugs characterized by having a piperazine moiety at C-7 of quinolone skeleton, and they have been used for the treatment of bacterial infections (Foroumadi et al., 2005) .
The compounds having a thiazolidinone nucleus are of interest due to their broad spectrum of biological activities such as bactericidal, fungicidal, antimicrobial, antiproliferative, antiviral, anticonvulsant, anticancer, and antiinflammatory activities (Vicini et al., 2008; Wang et al., 2011; Lv et al., 2010; Metwally et al., 2010; Balzarini et al., 2009; Havrylyuk et al., 2009; Subtelna et al., 2010; Mushtaque et al., 2012) .
Mannich bases, which are known to be physiologically reactive since their basic function rendering the molecule soluble in aqueous solvents when it is transformed into aminium salt, have been reported as potential biological agents (Karthikeyan et al., 2006) . N-Mannich bases have been used successfully to obtain prodrugs of amine as well as amide-containing drugs (Zhao et al., 2009) . Some Mannich bases derived from 1,2,4-triazole nucleus have been reported to possess protozocidal and antibacterial activity (Ashok et al., 2007; Almajan et al., 2009; Bayrak et al., 2009 Bayrak et al., , 2010 Demirbas et al., 2009; Bektas et al., 2010; Patole et al., 2006) .
Schiff bases have gained importance in medicinal and pharmaceutical fields due to their most versatile properties as organic synthetic intermediates and also possessing a broad range of biological activities, such as antituberculosis, anticancer, analgesic and anti-inflammatory, anticonvulsant, antibacterial, and antifungal activities (Patole et al., 2006, Hearn and Cynamon, 2004; Ren et al., 2002; Demirbas et al., 2002; Lohray et al., 2006) .
We envisage that hybrid compound incorporating a 4-(2-fluorophenylene)-piperazine core with several heterocyclic moieties responsible for biological activity in a single molecular frame could lead to the novel potent antimicrobial and antiurease agents. Highly substituted piperazines can be expected to increase antimicrobial activity probably by enhancing lipophilicity of molecule.
In continuation of our research program on the synthesis of hybrid molecules containing various heterocyclic moieties, we planned the synthesis of 4-(2-fluorophenyl)piperazine derivatives along with their antimicrobial and antiurease activities.
Results and discussion
The main aim of the present study is the synthesis and antimicrobial activity evaluation of new piperazine derivatives incorporating several heterocyclic moieties including 1,3-oxadiazole, 1,2,4-triazole, 1,3-oxa(thia)zole, penicillanic acid, and/or cephalosporanic acid. Synthesis of the intermediate and target compounds was performed according to the reactions outlined in Schemes 1, 2, and 3. The starting compound ethyl 1-piperazinecarboxylate (1) was provided commercially.
Ethyl 4-(4-amino-2-fluorophenyl)piperazine-1-carboxylate (3), that was obtained starting from compound 1 by two steps, was converted to the corresponding arylmethylenamino derivatives (4a-f) by the treatment with several aromatic aldehydes. In the FT-IR and 1 H NMR spectra of these compounds, no signal pointing the -NH 2 group was seen. Instead, additional signals derived from aldehyde moiety were recorded at the related chemical shift values in the 1 H NMR spectra. The cyclocondensation of compound 5, that was obtained from the reaction of 4 with benzylisocyanate, with ethyl bromoacetate or 4-chlorophenacyl bromide produced the corresponding hybrid molecules incorporating a 4-oxo-1,3-oxazolidine (6) or 4-chlorophenyl)-1,3-oxazole (7) nucleus in the 2-fluorophenylpiperazine-1-carboxylate skeleton. The 1 H and 13 C NMR spectra of compound 7 exhibited additional signals at aromatic region originated from 4-chlorophenyl nucleus as a result of condensation. Moreover, the elemental analyses and mass spectral data of derivatives 6 and 7 were compatible with the suggested structures.
The treatment of compound 3 with ethyl bromoacetate at room temperature in the presence of triethylamine resulted in the formation of compound 8. When compound 8 was converted to the corresponding hydrazide (9) by refluxing with hydrazine hydrate, the signals originated from ester function was disappeared in the 1 H and 13 C NMR spectra. Instead, new signals due to -NHNH 2 protons were seen at 5.93 and 9.09 ppm. Meanwhile, the stretching frequency band of this group was recorded at 3,313 cm -1 as a wide signal characteristic for the hydrazide structure. Compounds 6 and 7 gave mass fragmentation confirming the proposed structures.
The synthesis of compounds 10 and 11 was carried out by the treatment of compound 7 with the corresponding isothiocanates. These compounds displayed spectroscopic data and elemental analysis results consistent with the assigned structures.
The intramolecular cyclization of compound 10 generated the corresponding 1,3,4-thiazole compound (12) in acidic media. On the other hand, the basic treatment of compounds 10 and 11 caused to the cyclization of the (arylamino)carbonothioylhydrazino side change leading to the formation of 5-thioxo-4,5-dihydro-1H-1,2,4-triazol derivatives (13 and 14) . With the conversion of compounds 10 and 11 to compounds 12-14, two of NH signals were disappeared in the 1 H NMR spectra. It is well-known that type of compounds can stay in thioxo or mercapto tautomeric form. In the present study, compounds 13 and 14 are present predominately in the thioxo form as it was shown by the C=S band at 1,244-1,250 cm -1 in the FT-IR spectra of these compounds. Furthermore, the 1 H NMR spectra of compounds 13 and 14 revealed clearly the absence of the signal originated from SH proton, instead of that, two signals due to NH proton on 1,2,4-triazol ring was recorded at 10.45 (for 13) or 11.27 (for 14), that is characteristic for 4,5-dihydro-1H-1,2,4-triazoles.
The synthesis of Mannich bases (15-17) was performed by the reaction of compounds 13 and 14 with 6-aminopenicillanic acid, 6-apa (for 17) or 7-aminocephalosporanic acid, 7-aca (for 15 and 16) in tetrahydrofuran at room temperature in the presence of triethylamine and formaldehyde. The occurrence of the alkylaminomethylation was provided by the disappearance of signal for the proton at the N-1 nitrogen of the 1,2,4-triazole ring. Moreover, in 1 H and 13 C NMR spectra, additional signal corresponding to the 6-apa or 7-aca-ammonium salt was recorded at the related chemical shift value.
The conversion of arylcarbonothioylhydrazino side change to 4-chlorophenyl-3-phenyl-1,3-thiazole ring (18) was accomplished with the treatment of 4-chlorophenacyl bromide. This compound was characterized by spectroscopic techniques including 1 H NMR, 13 C NMR, FT-IR, EI-MS, and elemental analysis.
The synthesis of ethyl arylidenehydrazino-piperazine-1-carboxylate derivatives (19a-c) was performed by microwave irradiation of compound 9 with several aromatic aldehydes namely 3-hydroxy-4-methoxybenzaldehyde, pyridine-4-carbaldehyde, and 2-hydroxybenzaldehyde. In the FT-IR spectra of these arylidenehydrazino compounds, absorption bands characteristic for NH groups were visible in Ethyl 4- (2-fluoro-4-{[(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl) methyl]amino} phenyl)piperazine-1-carboxylate (20) was prepared from the reaction of compound 9 with CS 2 in the basic media. The attempts for aminoalkylations of compound (20) by Mannich reaction allowed the isolation of the corresponding products (21 and 22) after 4 (for 21) or 6 h (for 22) at room temperature. This idea originated from the intent to introduce the penicillanic acid or cephalosporanic acid nucleus to (piperazin-1-yl)-2-thioxo-1,3,4-oxadiazole skeleton. As different from 20, the NMR spectra of the obtained Mannich bases (21 and 22) displayed additional signals derived from penicillanic-or cephalosporanic-acid moiety and -CH 2 The synthesized compounds were assayed for their in vitro urease inhibitory activity against Jack bean urease. Two of those compounds showed perfect urease inhibition. No inhibitory effect was detected for other compounds. Thiourea with IC 50 value 54.56 ± 4.17 lg mL -1 was used as standard inhibitor. Among tested compounds, compound 15 was found to be the best inhibitory effect against urease with an IC 50 value of 4.67 ± 0.53 lg mL -1 . At the various final concentrations the compound 15 showed more inhibitory effect than standard urease inhibitor thiourea. Also, compound 17 has the highest inhibitory activity than thiourea. These compounds might be considered as potential antibiotics to treat infections.
All compounds were evaluated with regard to pancreatic lipase activity and compounds 12, 13, 14, and 15, which are 1,3,4-thiadizole or 1,2,4-triazole derivatives including also 4-fluorophenylpiperazine nucleus, showed moderate anti-lipase activities at final concentration of 6.25 lg mL -1 . No inhibitory effect was detected for other compounds. Orlistat, known pancreatic lipase inhibitor used as anti-obesity drug, showed inhibitory effect by 99 % at the same concentration.
Conclusion
This study reports microwave-assisted synthesis of some new hybrid molecules containing penicillanic acid or cephalosporanic acid moieties with some other pharmacophore heterocycles in a single structure. Hence herein we combined all these potential chemotherapeutic units, namely 1,2,4-triazole, 1,3-thiazole, 1,3-oxazole, 1,3,4-oxadiazole, piperazine, penicillanic acid, cephalosporanic acid moieties. The antimicrobial, antiurease, and antilipase screening studies were also performed in the study.
Among the synthesized compounds, the compounds containing 1,2,4-triazole and cephalosporanic-or penicillanic-acid moiety (15-17) displayed good-moderate activity on some of the test microorganisms. The highest activity was observed for compound 17 on Bc with the inhibition zone of 16 mm. This result is better than standard drug ampicillin. Moreover, compounds 15 and 17 exhibited an inhibitory effect against urease. Other compounds containing penicillanic acid or cephalosporanic acid core (21 and 22) displayed good-moderate activity against the test microorganisms. Furthermore, compounds 12, 13, 14, and 15, which are 1,3,4-thiadizole or 1,2,4-triazole derivatives including also 4-fluorophenylpiperazine nucleus, showed moderate anti-lipase activities at final concentration of 6.25 lg mL -1 .
Experimental

Chemistry
General information for chemicals
All the chemicals were purchased from Fluka Chemie AG Buchs (Switzerland) and used without further purification. The elemental analysis was performed on a Costech Elemental Combustion System CHNS-O elemental analyzer. All the compounds gave C, H, and N analysis within ±0.4 % of the theoretical values. The mass spectra were obtained on a Quattro LC-MS (70 eV) instrument.
Ethyl 4-(2-fluoro-4-nitrophenyl)piperazine-1-carboxylate (2) The solution of 3,4-difluoronitrobenzene (10 mmol) in excess amount of ethyl 1-piperazinecarboxylate (40 mmol) was allowed to reflux for 6 h (the progress of the reaction was monitored by TLC). Then, the mixture was poured into ice-water. The precipitated product was filtered off and recrystallized from ethanol. Ethyl 4-(4-amino-2-fluorophenyl)piperazine-1-carboxylate (3) Pd-C (5 mmol) catalyst was added to the solution of compound (2) (10 mmol) in n-butanol, and the mixture was refluxed in the presence of hydrazine hydrate (50 mmol) for 7 h. The progress of the reaction was monitored by TLC. Then, the catalyst was separated by filtration and the solvent was evaporated under reduced pressure. 
Ethyl 4-(4-{[(benzylamino)carbonyl]amino}-2-fluorophenyl) piperazine-1-carboxylate (5)
The mixture of compound 3 (10 mmol) and benzylisothiocyanate (10 mmol) in absolute ethanol was refluxed for 10 h. On cooling the reaction mixture to room temperature, a solid formed. This crude product was collected by filtration and recrystallized from ethanol. Ethyl 4-(4-{[3-benzyl-4-oxo-1,3-oxazolidin-2-ylidene]amino}-2-fluorophenyl)piperazine-1-carboxylate (6) The mixture of compound 5 (10 mmol) and ethyl bromoacetate in absolute ethanol was refluxed in the presence of dried sodium acetate (50 mmol) for 13 h. After removing the solvent under reduced pressure, a solid appeared. This crude product was washed water and the precipitated solid was recrystallized from ethanol:water (1:2 ? , 100).
The mixture of compound 5 (10 mmol) and 4-chlorophenacylbromide (10 mmol) in absolute ethanol was refluxed in the presence of dried sodium acetate (50 mmol) for 11 h. Then, the reaction mixture was cooled to room temperature and the precipitated salt was removed by filtration. After evaporating the solvent under reduced pressure, a solid appeared. This crude product recrystallized with ethyl acetate: petroleum ether (1:2 Ethyl 4-{4-[(2-ethoxy-2-oxoethyl)amino]-2-fluorophenyl} piperazine-1-carboxylate (8) To the mixture of compound 3 (10 mmol) and triethylamine (10 mmol) in dry tetrahydrofurane, ethylbromoacetate (10 mmol) was added drop by drop at 0-5°C. Then, the reaction mixture was allowed to reach room temperature and stirred for 14 h (the progress of the reaction was monitored by TLC). The precipitated triethylammonium salt was removed by filtration and the resulting solution was evaporated under reduced pressure to dryness. The obtained yellow solid was recrystallized from ethanol:water (1:2 
piperazine-1-carboxylate (11) The mixture of compound 9 (10 mmol) and phenylisothiocyanate (10 mmol) in absolute ethanol was heated under reflux for 10 h. On cooling the reaction mixture to room temperature, a white solid appeared. This crude product was filtered off and recrystallized from ethanol. Ethyl 4-(4-{[(5-anilino-1,3,4-thiadiazol-2-yl)methyl]amino}-2-fluorophenyl)piperazine-1-carboxylate (12) Concentrated sulfuric acid (64 mmol) was added to compound 11 (10 mmol) dropwise while stirring, and the reaction mixture was stirred in an ice bath for 15 min. Then, the mixture was allowed to reach room temperature and stirred for additional 2 h. The resulting solution was poured into ice cold water and made alkaline (pH 8) with ammonia. The precipitated product was filtered, washed with water, and recrystallized from dimethysulfoxide:water (1: 2H, arH), 2H, arH), 7.17 (brs, 1H, NH), 3H, arH), 7.56 (d, 1H, arH, J = 7.8 Hz) . 13 ? , 27), 457.16 ([M?1] ? , 100).
Ethyl 4- [2-fluoro-4-({[4-(4-fluorophenyl)-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl] 5.87 (brs, 2H, 2NH), 6.27 (brs, 2H, arH), 6.79 (brs, 1H, arH), 7. 45 (brs, 4H, arH Ethyl 4- (2-fluoro-4-{[(4-phenyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl) methyl] amino}phenyl)piperazine-1-carboxylate (14) A solution of compound 11 (10 mmol) in ethanol water (1:1) was refluxed in the presence of 2 N NaOH for 3 h. Then, the resulting solution was cooled to room temperature and acidified to pH 7 with 37 % HCl. 
